[1]
|
Paice JA, Ferrell B. The management of cancer pain[J]. Ca Cancer J Clin, 2011, 61:157-182. doi: 10.3322/caac.20112 |
[2]
|
Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO guidelines:a longitudinal follow up study of symptom prevalence, severity and etiology[J]. Pain, 2001, 93:247-257. doi: 10.1016/S0304-3959(01)00324-4 |
[3]
|
Coleman RE. Skeletal complications of malignancy[J]. Cancer, 1997, 80(8 Suppl):1588-1594. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1002/cncr.11136 |
[4]
|
Thapa D, Rastogi V, Ahuja V. Cancer pain managementcurrent status[J]. J Anaesthesiol Clin Pharmacol, 2011, 27:162-168. doi: 10.4103/0970-9185.81820 |
[5]
|
Gralow JR, Biermann JS, Farooki A, et al. NCCN task force report:bone health in cancer care[J]. J Natl Compr Canc Netw, 2009, 7(Suppl 3):S1-S35. http://www.ncbi.nlm.nih.gov/pubmed/23997241 |
[6]
|
Mercadante S, Arcuri E. Breakthrough pain in cancer patients:pathophysiology and treatment[J]. Cancer Treat Rev, 1998, 24:425-432. doi: 10.1016/S0305-7372(98)90005-6 |
[7]
|
Mercadante S. Malignant bone pain:pathophysiology and treatment[J]. Pain, 1997, 69:1-18. doi: 10.1016/S0304-3959(96)03267-8 |
[8]
|
Lipton A, Uzzo R, Amato RJ, et al. The science and practice of bone health in oncology:managing bone loss and metastasis in patient with solid tumors[J]. J Natl Compr Canc Netw, 2009, 7(Suppl 7):S1-S30. doi: 10.6004/jnccn.2009.0080 |
[9]
|
Portenoy RK, Payne D, Jacobsen P. Breakthrough pain:characteristics and impact in patients with cancer pain[J]. Pain, 1999, 81:129-134. doi: 10.1016/S0304-3959(99)00006-8 |
[10]
|
Luger, NM, Honore P, Sabino MAC, et al. Osteoprotegerin diminishes advanced bone cancer pain[J]. Cancer Res, 2001, 61:4038-4047. http://europepmc.org/abstract/MED/11358823 |
[11]
|
Wacnik PW, Kehl LJ, Trempe TM, et al. Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan[J]. Pain, 2003, 101:175-186. doi: 10.1016/S0304-3959(02)00312-3 |
[12]
|
Pacharinsak C, Beitz A. Animal models of cancer pain[J]. Comp Med, 2008, 58:220-233. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704117/?report=classic |
[13]
|
Medhurst SJ, Walker K, Bowes M, et al. A rat model of bone cancer pain[J]. Pain, 2002, 96:129-140. doi: 10.1016/S0304-3959(01)00437-7 |
[14]
|
Vivancos GG, Verri WA Jr, Cunha TM, et al. An electronic pressure-meter nociception paw test for rats[J]. Braz J Med Biol Res, 2004, 37:391-399. doi: 10.1590/S0100-879X2004000300017 |
[15]
|
Dornelas CA, Almeida PR, Nascimento GL, et al. Experimental model of Walker 256 carcinosarcoma in rats bladder[J]. Acta Cir Bras, 2006, 21:38-42. doi: 10.1590/S0102-86502006000100009 |
[16]
|
Buffon A, Ribeiro VB, Schanoki AS, et al. Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour[J]. Mol Cell Biochem, 2006, 281:189-195. doi: 10.1007/s11010-006-1029-z |